Third largest global contract research, development and manufacturing organization (CRDMO) that provides biopharmaceutical partners with fully integrated services to support drug discovery, development and manufacturing for both drug substance and drug product.
- 2005 Year invested
Global, multi-product biologics contract development and manufacturing organization (CDMO), focused on development and cGMP manufacture of microbial-based therapeutics, from preclinical to commercial production.
Global contract development and manufacturing organization (CDMO) focused on Sterile Injectables, spanning development to full scale commercial production across Oncology/High Potency, Blow-Fill-Seal and multi format vial streams.
Global supplier of sterile injectable pharmaceutical drugs spanning high potency, blow fill seal and multi format vials.
Subsidiary of Bridgewest Group and parent company to NovaCina, CDMO, and LumaCina, global supplier of sterile injectable pharmaceutical drugs.
Global clinical-stage biotechnology company utilizing proprietary Conditionally Active Biologics (CAB) technology to develop novel monoclonal antibody and other protein therapeutic product candidates with more selective targeting, greater efficacy, and more cost-efficient and predictable manufacturing than traditional antibodies.
SuiteFiles is a cloud based document management system for small and medium businesses.
An intelligent business management platform, built by professional services, for professional services.
An award winning global technology services firm and proud Microsoft Partner with Gold Status across numerous competencies. Provoke helps its clients flourish by delivering impactful software that delights users. Provoke believes clients deserve better than competitive services that are late, over-engineered, and over budget with outputs that miss the point.
Preclinical biopharmaceutical company developing single-target and combo-therapeutic CAR-T therapies that are fine-tuned to comprehensively target a patient's solid tumors and their microenvironments.
An R&D service company providing development services for state of the art IP, product design, and technology platforms.
A fabless semiconductor company providing state of the art, disruptive chipset solutions in Power Management and Smart Audio across a wide spectrum of applications from Mobile devices, IoT, Personal Computers, and Cloud Servers.
- 2019 Year invested
Clinical stage, therapeutic company developing innovative, differentiated CAB antibody therapies in greater China. Himalaya Therapeutics strives to deliver safer, more potent cancer therapies timely and cost effectively to patients.
The power of location intelligence is at work, enabling businesses to create frictionless experiences. Macro- and micro-location solutions turn physical-world data into action for operators, marketers, and analysts looking to improve their omnichannel strategies.
Preclinical biopharmaceutical development company focusing on best-in-class small and large molecule therapeutics, and cell-therapy, to address the unmet medical needs of patients.
- 2015 Year invested
BioOra Limited is a partnership between Bridgewest Ventures and the Malaghan Institute of Medical Research. Through automated manufacturing of CAR-T cell immunotherapy, BioOra can deliver life-saving immunotherapies at substantially less cost.
A Bridgewest Ventures New Zealand Incubator company that delivers a test automation platform, SaaS, and ERP automated testing and release management, leveraging AI to lower costs and de-risk software upgrade acceptance.
- 2021 Year invested
Pioneering advancements in Artificial Intelligence leverage expert data science for AI algorithms and IOT smart devices from edge to cloud, that garner meaningful sensory data insights and establish critical building blocks for ethical AI.
A software development company that develops, maintains, and enhances software solutions to help companies build digital products and scale teams. Modernization and optimization of business software solutions through dedicated teams enable companies to focus on the core aspects of running their business.
BioViros will be New Zealand’s first CDMO providing development services and GMP manufacturing of lentivirus vectors, both for R&D purposes and clinical trials of cell therapies.
Pioneers of the biological scalable nanorod technology platform with applications in immunodiagnostics.
A biotechnology company that leverages patented 3D printed chromatography columns for separating and purifying biological molecules from a fluid mixture. The crucial technology serves the medicinal therapeutics industry, enabling purification of DNA, RNA, viruses, and antibodies that are used in vaccines and cell and gene therapies.
A dynamic data-driven platform that leverages IoT integrated monitoring and device management for phytotechnology turnkey solutions that can restore, regenerate, and reclaim contaminated earth.
A medical technology company with a novel revascularization device to help plastic surgeons restore form and function for patients who are left disfigured from disease and deformity.
TheiaNova is developing transformative, new, non-invasive therapies for patients with vision impairment due to ectatic vision disorders.
Contract research organization (CRO) and consultation services for clinical trials specializing in CAR-T cell therapies, personalized medicines, and immunology-based treatments.
A future-driven bio-based foamed material platform that addresses the global plastics crisis by enabling current polystyrene factory equipment to mold a sustainably sourced, functional replacement for Styrofoam with potential for multiple end of life options.
Highly engineered, specification grade commercial lighting solutions designed with application centric approach and compatibility for a broad range of controls.
- 2017 Year invested
Real estate company with a broad global portfolio spanning speciality commerical sites, business centers, residential and mixed-used buildings.
- 2009 Year invested
Luminoma is pioneering a non-invasive skin cancer screening tool. By detecting molecular changes in cells, Luminoma delivers rapid and accurate diagnosis, reducing patient stress and healthcare system burden.
- 2023 Year invested
